Silence Therapeutics reported $-12.46M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -72.47M 845K Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Silence Therapeutics USD -12.46M 13.78M Dec/2025